These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22981335)

  • 1. Pyrrolo[2,3-b]quinoxalines as inhibitors of firefly luciferase: their Cu-mediated synthesis and evaluation as false positives in a reporter gene assay.
    Nakhi A; Rahman MS; Kishore R; Meda CL; Deora GS; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6433-41. PubMed ID: 22981335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors.
    Liu Y; Fang J; Cai H; Xiao F; Ding K; Hu Y
    Bioorg Med Chem; 2012 Sep; 20(18):5473-82. PubMed ID: 22898255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.
    Heitman LH; van Veldhoven JP; Zweemer AM; Ye K; Brussee J; IJzerman AP
    J Med Chem; 2008 Aug; 51(15):4724-9. PubMed ID: 18646744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays.
    Hampf M; Gossen M
    Anal Biochem; 2006 Sep; 356(1):94-9. PubMed ID: 16750160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 5-benzyl-3-phenyl-4,5-dihydroisoxazoles and 5-benzyl-3-phenyl-1,4,2-dioxazoles as potent firefly luciferase inhibitors.
    Poutiainen PK; Palvimo JJ; Hinkkanen AE; Valkonen A; Väisänen TK; Laatikainen R; Pulkkinen JT
    J Med Chem; 2013 Feb; 56(3):1064-73. PubMed ID: 23286196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporter enzyme inhibitor study to aid assembly of orthogonal reporter gene assays.
    Ho PI; Yue K; Pandey P; Breault L; Harbinski F; McBride AJ; Webb B; Narahari J; Karassina N; Wood KV; Hill A; Auld DS
    ACS Chem Biol; 2013 May; 8(5):1009-17. PubMed ID: 23485150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
    Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C
    J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity.
    Guillon J; Moreau S; Mouray E; Sinou V; Forfar I; Fabre SB; Desplat V; Millet P; Parzy D; Jarry C; Grellier P
    Bioorg Med Chem; 2008 Oct; 16(20):9133-44. PubMed ID: 18819813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.
    Guillon J; Mouray E; Moreau S; Mullié C; Forfar I; Desplat V; Belisle-Fabre S; Pinaud N; Ravanello F; Le-Naour A; Léger JM; Gosmann G; Jarry C; Déléris G; Sonnet P; Grellier P
    Eur J Med Chem; 2011 Jun; 46(6):2310-26. PubMed ID: 21458112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-pot synthesis of pyrrolo[1,2-a]quinoxalines.
    Huang A; Liu F; Zhan C; Liu Y; Ma C
    Org Biomol Chem; 2011 Nov; 9(21):7351-7. PubMed ID: 21894335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolo[1,2-a]quinoxal-5-inium salts and 4,5-dihydropyrrolo[1,2-a]quinoxalines: Synthesis, activity and computational docking for protein tyrosine phosphatase 1B.
    Sánchez-Alonso P; Griera M; García-Marín J; Rodríguez-Puyol M; Alajarín R; Vaquero JJ; Rodríguez-Puyol D
    Bioorg Med Chem; 2021 Aug; 44():116295. PubMed ID: 34246920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
    Guillon J; Le Borgne M; Rimbault C; Moreau S; Savrimoutou S; Pinaud N; Baratin S; Marchivie M; Roche S; Bollacke A; Pecci A; Alvarez L; Desplat V; Jose J
    Eur J Med Chem; 2013 Jul; 65():205-22. PubMed ID: 23711832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors.
    Wu P; Su Y; Liu X; Zhang L; Ye Y; Xu J; Weng S; Li Y; Liu T; Huang S; Yang B; He Q; Hu Y
    Eur J Med Chem; 2011 Nov; 46(11):5540-8. PubMed ID: 21945250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolo[1,2-a]quinoxalines: Insulin Mimetics that Exhibit Potent and Selective Inhibition against Protein Tyrosine Phosphatase 1B.
    García-Marín J; Griera M; Sánchez-Alonso P; Di Geronimo B; Mendicuti F; Rodríguez-Puyol M; Alajarín R; de Pascual-Teresa B; Vaquero JJ; Rodríguez-Puyol D
    ChemMedChem; 2020 Oct; 15(19):1788-1801. PubMed ID: 32909701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of inhibition of firefly luciferase by oxyluciferin and dehydroluciferyl-adenylate.
    Ribeiro C; Esteves da Silva JC
    Photochem Photobiol Sci; 2008 Sep; 7(9):1085-90. PubMed ID: 18754056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firefly luciferase inhibition.
    Leitão JM; Esteves da Silva JC
    J Photochem Photobiol B; 2010 Oct; 101(1):1-8. PubMed ID: 20655239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II.
    Desplat V; Moreau S; Gay A; Fabre SB; Thiolat D; Massip S; Macky G; Godde F; Mossalayi D; Jarry C; Guillon J
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):204-15. PubMed ID: 20222763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of an appropriate reporter assay: Heliotrine interferes with GAL4/upstream activation sequence-driven reporter gene systems.
    Luckert C; Hessel S; Lampen A; Braeuning A
    Anal Biochem; 2015 Oct; 487():45-8. PubMed ID: 26212314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors.
    Wu P; Su Y; Liu X; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2012 May; 20(9):2837-44. PubMed ID: 22480851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.